Kincell Bio is a contract development and manufacturing organization that provides end‑to‑end cell therapy services, including analytical development, process development, and GMP‑compliant manufacturing. It helps biotech and pharma companies move therapies from early clinical stages through pivotal trials to commercial supply with tailored, expert‑driven strategies and rigorous quality testing.
Funding
$22M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
KLNFounders
Product
Problem
Developing and manufacturing cell therapies involves complex, highly regulated processes that require specialized expertise, extensive analytical testing, and scalable GMP production. Companies often lack the integrated capabilities to move from early‑stage development through clinical supply to commercial launch efficiently.
Solution
Kincell Bio operates as a contract development and manufacturing organization (CDMO) focused on cell therapy products. It provides end‑to‑end services that span analytical development, process development, and GMP manufacturing, enabling clients to advance therapies from early clinical stages to pivotal and commercial supply. The company’s expert‑driven approach tailors development strategies to each product, ensuring right‑first‑time performance and consistent quality. Integrated analytical testing verifies product potency, purity, and consistency throughout development. Scalable GMP manufacturing facilities produce cell therapy batches that meet stringent regulatory standards, supporting seamless transition across development phases.
Target Audience
Primary customers are biotechnology and pharmaceutical companies developing autologous or allogeneic cell therapies that require CMC development, analytical validation, and GMP manufacturing support.
Features
- Comprehensive analytical development services for potency, identity, and safety testing of cell therapy products
- Phase‑appropriate process development that optimizes manufacturing workflows and reduces cycle times
- GMP‑compliant manufacturing across early, late‑phase, and commercial scales with strict quality control
- Integrated CMC support enabling smooth handoff between development stages and regulatory submissions
- Flexible, client‑centric project management to customize development pathways for diverse cell therapy modalities